NCT03766425View on ClinicalTrials.gov

Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy.

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

June 14, 2017

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions
Eye DiseasesOptic Nerve DamageGlaucoma Surgery
Interventions
DRUG

Aflibercept

subconjunctival injection

DRUG

Mitomycin

subconjunctival injection

Trial Locations (1)

20-059

Medical University of Lublin, Lublin

All Listed Sponsors
lead

Medical University of Lublin

OTHER

NCT03766425 - Comparison of Efficacy and Safety of Mitomycin and Aflibercept Used to Support Primary Trabeculectomy. | Biotech Hunter | Biotech Hunter